
AdWiki Webring Site
| SELECT YOUR LANGUAGE:
ar |
id |
bg |
ca |
ceb |
cs |
da |
de |
et |
en / / |
es |
eo |
fr |
gr |
he |
hr |
it |
ko |
lt |
hu |
nl |
ja |
no |
pl |
pt |
ru |
ro |
sk |
sl |
sr |
fi |
sv |
te |
tr |
uk |
zh 
Aselizumab
From Wikipedia, the free encyclopedia
Aselizumab is an immunosuppressive drug. It binds to CD62L.
|
Immunomodulators - Immunosuppressants - Immunosuppressive drugs (L04) |
|
| Extracellular |
|
|
CD3 ( Muromonab-CD3, Teplizumab, Visilizumab) · CD4 ( Keliximab, Zanolimumab) · CD11a ( Efalizumab) · CD20 ( Ocrelizumab, Pascolizumab) · CD23 ( Lumiliximab) · IL-2/CD25 ( Basiliximab, Daclizumab, Inolimomab) · CD40 ( Teneliximab) · CD62L/L-selectin ( Aselizumab) · CD147/Basigin ( Gavilimomab, Ziralimumab) · CD154 ( Ruplizumab)
BLyS (Belimumab) · Complement component 5 (Eculizumab) · CTLA-4 (Ipilimumab) · CAT (Metelimumab) · Immunoglobulin E (Omalizumab) · Integrin (Natalizumab) · Interleukin 5 (Mepolizumab) · Interleukin-6 receptor (Tocilizumab) · TNFs (Infliximab, Adalimumab, Certolizumab pegol, Afelimomab, Golimumab) · LFA-1 (Odulimomab)
other monoclonal: Atlizumab, Atorolimumab, Bertilimumab, Cedelizumab, Clenoliximab, Dorlimomab aritox, Dorlixizumab, Elsilimomab, Erlizumab, Faralimomab, Fontolizumab, Galiximab, Gantenerumab, Gomiliximab, Ibalizumab, Lebrilizumab, Lerdelimumab, Maslimomab, Morolimumab, Nerelimomab, Otelixizumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Toralizumab, Ustekinumab, Vapaliximab, Vepalimomab, Zolimomab aritox
Polyclonal: Anti-thymocyte globulin
|
|
|
|
|
|
|
|
|
|
|
| Intracellular |
|
|
|
Humanized monoclonal antibodies ("-zu-") |
|
| "-tuzu-" (tumor) |
Alemtuzumab, Bevacizumab/ Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Dacetuzumab, Elotuzumab, Etaracizumab, Etaratuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab, Nimotuzumab, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Trastuzumab, Tucotuzumab celmoleukin
|
|
| "-lizu-" (immune system) |
Aselizumab, Atlizumab, Apolizumab, Cedelizumab, Certolizumab pegol, Daclizumab, Eculizumab, Efalizumab, Epratuzumab, Erlizumab, Fontolizumab, Ibalizumab, Lebrilizumab, Mepolizumab, Natalizumab, Ocrelizumab, Omalizumab, Pascolizumab, Pexelizumab, Reslizumab, Rovelizumab, Ruplizumab, Siplizumab, Talizumab, Teplizumab, Tocilizumab, Toralizumab, Visilizumab
|
|
| "-bazu-" (bacterial) |
|
|
| "-cizu-" (cardiovascular) |
|
|
| "-neuzu-" (nervous system) |
|
|
| "-toxazu-" (toxin as target) |
|
|
| "-vizu-" (viral infections) |
|
|
Change language: All |
Arabic  |
Indonesian  |
Bulgarian  |
Catalan  |
Cebuano  |
Czech  |
Danish  |
German  |
Estonian  |
English / /  |
Spanish  |
Esperanto  |
French  |
Greek  |
Hebrew  |
Croatian  |
Italian  |
Korean  |
Lithuanian  |
Hungarian  |
Flemish / Dutch  |
Japanese  |
Norwegian  |
Polish  |
Portugues  |
Russian  |
Romanian  |
Slovakian  |
Slovenian  |
Serbian  |
Suomi / Finish  |
Swedish  |
Iranian  |
Turkish  |
Ukrainian  |
Chinese
MORE LINKS...
Autorem skryptu AdWiki v0.62 (2007) jest husky83 Licencję na skrypt dla strony DAWAJ.INFO posiada dzankes
Wikipedia® jest zarejestrowanym znakiem towarowym Wikimedia Foundation |